Citalopram.
Citalopram is a selective serotonin (5-HT) reuptake inhibitor (SSRI) developed by H. Lundbeck A/S in Denmark. It is the most selective serotonin antidepressant with proven efficacy, a favourable pharmacokinetic profile and a low potential for interactions with other concomitant medication. The drug has a low incidence of side effects, even when compared to the other SSRIs and good patient compliance and satisfaction is a feature of this drug. These factors make the drug a good choice for depressed patients who require continuation and long-term treatment, as well as for elderly patients. Copyright 2000 John Wiley & Sons, Ltd.
Joubert
Andre F.
AF
Lundbeck Institute, Grevinde Danners Palæ, Skodsborg strandvej 113, DK 2942 Skodsburg, Denmark.
Sánchez
Connie
C
Larsen
Frank
F